Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Geynisman

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Urology Case Reports|May 16, 2023
Between the Hammer and Anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapyDavid Strauss, Briana Kaplunov, Alexander Kutikov, et al.
Urologic Oncology|April 5, 2023
Corrigendum to real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States [Urologic oncology: Seminars and original investigations 40 (2022) 195.e1-195.e11]Daniel M Geynisman, Edward Broughton, Yi Hao, et al.
Urologic Oncology|December 15, 2021
Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United StatesDaniel M Geynisman, Edward Broughton, Yi Hao, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2023
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate CancerElizabeth A Handorf, J Robert Beck, Andres Correa, et al.
Cancer Biology & Therapy|July 21, 2017
Mismatch repair deficient metastatic colon cancer and urothelial cancer: A case report of sequential immune checkpoint therapyPooja Ghatalia, Rajeswari Nagarathinam, Harry Cooper, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic reviewDaniel M Geynisman, Chun-Ru Chien, Fabrice Smieliauskas, et al.
Urologic Oncology|August 11, 2019
Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancerChethan Ramamurthy, Elizabeth A Handorf, Andres F Correa, et al.
Urology Case Reports|December 4, 2018
Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumorAeen M Asghar, Andrew G McIntosh, Alexander Kutikov, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 1, 2014
A review of economic impact of targeted oral anticancer medicationsChan Shen, Chun-Ru Chien, Daniel M Geynisman, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Urology Case Reports|May 16, 2023
Between the Hammer and Anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapyDavid Strauss, Briana Kaplunov, Alexander Kutikov, et al.
Urologic Oncology|April 5, 2023
Corrigendum to real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States [Urologic oncology: Seminars and original investigations 40 (2022) 195.e1-195.e11]Daniel M Geynisman, Edward Broughton, Yi Hao, et al.
Urologic Oncology|December 15, 2021
Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United StatesDaniel M Geynisman, Edward Broughton, Yi Hao, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2023
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate CancerElizabeth A Handorf, J Robert Beck, Andres Correa, et al.
Cancer Biology & Therapy|July 21, 2017
Mismatch repair deficient metastatic colon cancer and urothelial cancer: A case report of sequential immune checkpoint therapyPooja Ghatalia, Rajeswari Nagarathinam, Harry Cooper, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic reviewDaniel M Geynisman, Chun-Ru Chien, Fabrice Smieliauskas, et al.
Urologic Oncology|August 11, 2019
Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancerChethan Ramamurthy, Elizabeth A Handorf, Andres F Correa, et al.
Urology Case Reports|December 4, 2018
Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumorAeen M Asghar, Andrew G McIntosh, Alexander Kutikov, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 1, 2014
A review of economic impact of targeted oral anticancer medicationsChan Shen, Chun-Ru Chien, Daniel M Geynisman, et al.
Pageof 19